Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 8Neoplasms 4Colorectal Neoplasms 4Breast Neoplasms 3Small Cell Lung Carcinoma 2Rectal Neoplasms 2Precancerous Conditions 2Male Urogenital Diseases 2Lung Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Vascular Diseases 1Thrombocytopenia 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Non-melanoma Skin Cancer 1Neurotoxicity Syndromes 1Myocardial Ischemia 1Myocardial Infarction 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphedema 1Leukemia, Myelomonocytic, Chronic 1

Interventions

padeliporfin 4Lycopene 3Vitamin E 2Tea 2Selenium 2Cholecalciferol 2Therapeutics 1Sugars 1Intraoperative Neurophysiological Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Male Urogenital Diseases × Vitamin E × Clear all
NCT00744549 2018-02-14

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

University Health Network, Toronto

Phase 2 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00844792 2017-10-26

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡